• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人滋养层细胞表面抗原2是一种肿瘤相关钙信号转导分子。

Human Trop-2 is a tumor-associated calcium signal transducer.

作者信息

Ripani E, Sacchetti A, Corda D, Alberti S

机构信息

Department of Cell Biology and Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy.

出版信息

Int J Cancer. 1998 May 29;76(5):671-6. doi: 10.1002/(sici)1097-0215(19980529)76:5<671::aid-ijc10>3.0.co;2-7.

DOI:10.1002/(sici)1097-0215(19980529)76:5<671::aid-ijc10>3.0.co;2-7
PMID:9610724
Abstract

Trop-2/EGP-1/GA733-1 is a recently identified cell surface glycoprotein highly expressed by human carcinomas. The cytoplasmic tail of Trop-2 possesses potential serine and tyrosine phosphorylation sites and a phosphatidyl-inositol binding consensus sequence. Thus, we investigated whether Trop-2 might be a functional signaling molecule. Using the fluorescent probe Fura-2, we assayed the cytoplasmic calcium levels in human cancer cells stimulated with anti-Trop-2 or control antibodies. Three anti-Trop-2 MAbs, Rs7-7G11, MOv16 and 162-46.2 specifically induced a transient intracellular calcium level increment in up to 40% of the experiments performed. Polyclonal antisera recognizing recombinant Trop-2 molecules possessed a much lower stimulation efficiency. The average latency of antibody-induced Ca2+ rise for OvCa-432 cells was 64+/-26 sec. Internal Ca2+ concentrations reached peaks of 190+/-24 nM vs. basal levels of 61+/-4 nM and returned to baseline within 193+/-37 sec. Similar values were obtained in MCF-7 cells. For comparison, stimulation of P2-purinergic receptors on MCF-7 and OvCa-432 cells induced a Ca2+ rise in most cases, leading to average internal Ca2+ concentrations of 297+/-41 and 391+/-39 nM, respectively. Our findings show that Trop-2 transduces an intracellular calcium signal, are consistent with the hypothesis that it acts as a cell surface receptor and support a search for a physiological ligand.

摘要

Trop-2/EGP-1/GA733-1是一种最近发现的细胞表面糖蛋白,在人类癌症中高度表达。Trop-2的细胞质尾部具有潜在的丝氨酸和酪氨酸磷酸化位点以及磷脂酰肌醇结合共有序列。因此,我们研究了Trop-2是否可能是一种功能性信号分子。使用荧光探针Fura-2,我们检测了用抗Trop-2或对照抗体刺激的人类癌细胞中的细胞质钙水平。三种抗Trop-2单克隆抗体Rs7-7G11、MOv16和162-46.2在高达40%的实验中特异性地诱导了细胞内钙水平的短暂升高。识别重组Trop-2分子的多克隆抗血清具有低得多的刺激效率。OvCa-432细胞中抗体诱导的Ca2+升高的平均延迟时间为64±26秒。内部Ca2+浓度达到峰值190±24 nM,而基础水平为61±4 nM,并在193±37秒内恢复到基线。在MCF-7细胞中获得了类似的值。作为比较,在大多数情况下,刺激MCF-7和OvCa-432细胞上的P2嘌呤能受体会诱导Ca2+升高,导致平均内部Ca2+浓度分别为297±41和391±39 nM。我们的研究结果表明,Trop-2转导细胞内钙信号,这与它作为细胞表面受体起作用的假设一致,并支持寻找生理配体。

相似文献

1
Human Trop-2 is a tumor-associated calcium signal transducer.人滋养层细胞表面抗原2是一种肿瘤相关钙信号转导分子。
Int J Cancer. 1998 May 29;76(5):671-6. doi: 10.1002/(sici)1097-0215(19980529)76:5<671::aid-ijc10>3.0.co;2-7.
2
Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas.人癌表达的细胞表面糖蛋白Trop-2编码基因的克隆。
Int J Cancer. 1995 Sep 4;62(5):610-8. doi: 10.1002/ijc.2910620520.
3
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers.赛托珠单抗戈维汀(IMMU-132),一种抗人滋养层细胞表面抗原2/伊立替康活性代谢物(SN-38)抗体药物偶联物:在胰腺癌、胃癌及其他癌症中的特性与疗效
Bioconjug Chem. 2015 May 20;26(5):919-31. doi: 10.1021/acs.bioconjchem.5b00223. Epub 2015 May 8.
4
TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.TROP-1/上皮细胞黏附分子(Ep-CAM)和CD24是卵巢癌治疗的潜在候选靶点。
Int J Clin Exp Pathol. 2015 May 1;8(5):4705-14. eCollection 2015.
5
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.高等级、化疗耐药的原发性卵巢癌细胞系过度表达人滋养层细胞表面标志物(Trop-2),并对 hRS7(一种人源化单克隆抗 Trop-2 抗体)的免疫治疗高度敏感。
Gynecol Oncol. 2011 Jul;122(1):171-7. doi: 10.1016/j.ygyno.2011.03.002. Epub 2011 Mar 30.
6
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.细胞质 Trop-1/Ep-CAM 过表达与淋巴结阳性乳腺癌的良好预后相关。
Jpn J Clin Oncol. 2012 Dec;42(12):1128-37. doi: 10.1093/jjco/hys159. Epub 2012 Oct 16.
7
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models.RN927C是一种具有增强稳定性的位点特异性Trop-2抗体药物偶联物(ADC),在临床前实体瘤模型中具有高效性。
Mol Cancer Ther. 2016 Nov;15(11):2698-2708. doi: 10.1158/1535-7163.MCT-16-0431. Epub 2016 Aug 31.
8
Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2.人癌表达的细胞表面分子Trop-2的生化特性:单克隆抗体T16和MOv-16识别Trop-2的确切证据。
Hybridoma. 1992 Oct;11(5):539-45. doi: 10.1089/hyb.1992.11.539.
9
TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling.TROP-2 通过双重抑制 IGF-1R 和 ALK 信号通路发挥抑癌作用。
Gynecol Oncol. 2019 Jan;152(1):185-193. doi: 10.1016/j.ygyno.2018.10.039. Epub 2018 Nov 12.
10
Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2.小鼠TROP2基因的克隆:TROP-2胞质结构域中PIP2结合序列的保守性
Int J Cancer. 1998 Jan 19;75(2):324-30. doi: 10.1002/(sici)1097-0215(19980119)75:2<324::aid-ijc24>3.0.co;2-b.

引用本文的文献

1
Immunohistochemical examination of CD163 and TROP2 expression levels in ovarian endometriosis.卵巢子宫内膜异位症中CD163和TROP2表达水平的免疫组织化学检查。
J Mol Histol. 2025 Aug 22;56(5):271. doi: 10.1007/s10735-025-10569-2.
2
Expression patterns of TROP2 and Nectin-4 in oropharyngeal squamous cell carcinoma in relation to HPV status: potential biomarkers for targeted therapy.口咽鳞状细胞癌中TROP2和Nectin-4的表达模式与HPV状态的关系:靶向治疗的潜在生物标志物
Ther Adv Med Oncol. 2025 Aug 18;17:17588359251361877. doi: 10.1177/17588359251361877. eCollection 2025.
3
Genomic Predictive Biomarkers in Breast Cancer: The and .
乳腺癌中的基因组预测生物标志物:以及。 (你提供的原文似乎不完整,翻译可能不太准确,你可补充完整原文后再让我翻译)
Int J Mol Sci. 2025 Jul 28;26(15):7300. doi: 10.3390/ijms26157300.
4
Preclinical evaluation of a novel antibody-drug conjugate OBI-992 for Cancer therapy.新型抗体药物偶联物OBI-992用于癌症治疗的临床前评估。
Sci Rep. 2025 Mar 13;15(1):8735. doi: 10.1038/s41598-025-92697-z.
5
Large, recursive membrane platforms are associated to Trop-1, Trop-2, and protein kinase signaling for cell growth.大型递归膜平台与Trop-1、Trop-2以及细胞生长的蛋白激酶信号传导相关。
Mol Biol Cell. 2025 Mar 1;36(3):ar38. doi: 10.1091/mbc.E24-06-0267. Epub 2025 Jan 9.
6
The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in cystic epithelial cells revealing a potential new target for polycystic kidney disease.肿瘤相关钙信号转导蛋白2(TACSTD2)癌基因在囊性上皮细胞中上调,揭示了多囊肾病的一个潜在新靶点。
PLoS Genet. 2024 Dec 12;20(12):e1011510. doi: 10.1371/journal.pgen.1011510. eCollection 2024 Dec.
7
Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes.揭示乳腺癌治疗的未来:前沿的抗体药物偶联物策略和临床结果。
Breast. 2024 Dec;78:103830. doi: 10.1016/j.breast.2024.103830. Epub 2024 Oct 28.
8
Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer.基于转移性三阴性乳腺癌中的应用,加拿大专家关于 Sacituzumab Govitecan 的安全性概述和毒性管理策略的建议。
Curr Oncol. 2024 Sep 21;31(9):5694-5708. doi: 10.3390/curroncol31090422.
9
Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities.华支睾吸虫相关胆管癌中的表观遗传生物标志物和 Wnt/β-连环蛋白通路:治疗机会的范围综述。
PLoS Negl Trop Dis. 2024 Sep 5;18(9):e0012477. doi: 10.1371/journal.pntd.0012477. eCollection 2024 Sep.
10
TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.TROP2在三阴性乳腺癌循环肿瘤细胞(CTCs)中高表达,是上皮间质转化CTCs的潜在标志物。
Mol Ther Oncol. 2024 Jan 10;32(1):200762. doi: 10.1016/j.omton.2024.200762. eCollection 2024 Mar 21.